Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH

Mar 12, 2025

Raichur (Karnataka) [India], March 12: Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee...

Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis

Aug 30, 2025

Pennington (New Jersey) [US] / Ahmedabad (Gujarat) [India], August 30: Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., a global innovation led...